Development of a multicomponent implementation strategy to reduce upper gastrointestinal bleeding risk in patients using warfarin and antiplatelet therapy, and protocol for a pragmatic multilevel randomized factorial pilot implementation trial.
Jacob E KurlanderDanielle HelminskiMichael LanhamJennifer L HenstockKelley M KidwellSarah L KreinSameer D SainiCaroline R RichardsonRaymond De VriesKenneth ResnicowAllison Laboon RuffDavid M WallaceElizabeth K JonesLinda K PerryJacqueline ParsonsNghi HaTina Alexandris-SouphisDale DedrickElizabeth AldridgeGeoffrey D BarnesPublished in: Implementation science communications (2022)
ClinicalTrials.gov NCT05085405 . Registered on October 19, 2021-retrospectively registered.
Keyphrases
- antiplatelet therapy
- study protocol
- end stage renal disease
- primary care
- phase iii
- acute coronary syndrome
- healthcare
- percutaneous coronary intervention
- ejection fraction
- randomized controlled trial
- phase ii
- open label
- chronic kidney disease
- newly diagnosed
- clinical trial
- double blind
- quality improvement
- venous thromboembolism
- peritoneal dialysis
- placebo controlled
- atrial fibrillation
- coronary artery disease
- patient reported
- direct oral anticoagulants